Anti-VEGF monotherapy treatment strategies for neovascular AMD

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter provides a review of the discovery of anti-vascular endothelial growth factor (VEGF) agents, the evolution of drug development, and the refinement of evidence-based treatment strategies for neovascular AMD.

Original languageEnglish (US)
Title of host publicationStudies on Retinal and Choroidal Disorders
PublisherHumana Press Inc.
Pages479-499
Number of pages21
ISBN (Electronic)9781617796067
ISBN (Print)9781617796050
DOIs
StatePublished - Jan 1 2012

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Anti-VEGF monotherapy treatment strategies for neovascular AMD'. Together they form a unique fingerprint.

  • Cite this

    Kovach, J. L., Schwartz, S. G., Flynn, H. W., & Scott, I. U. (2012). Anti-VEGF monotherapy treatment strategies for neovascular AMD. In Studies on Retinal and Choroidal Disorders (pp. 479-499). Humana Press Inc.. https://doi.org/10.1007/978-1-61779-606-7_23